Immunomodulatory and Antioxidant Drugs in Glaucoma Treatment

Glaucoma, a group of diseases characterized by progressive retinal ganglion cell loss, cupping of the optic disc, and a typical pattern of visual field defects, is a leading cause of severe visual impairment and blindness worldwide. Elevated intraocular pressure (IOP) is the leading risk factor for...

Descripción completa

Detalles Bibliográficos
Autores principales: Buonfiglio, Francesco, Pfeiffer, Norbert, Gericke, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535738/
https://www.ncbi.nlm.nih.gov/pubmed/37765001
http://dx.doi.org/10.3390/ph16091193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535738/
https://www.ncbi.nlm.nih.gov/pubmed/37765001
http://dx.doi.org/10.3390/ph16091193

Ejemplares similares